medicare semaglutide to Cover Weight-Loss Drug Wegovy for Certain Patients Medicare Prescriptions for Wegovy Jumped

Healthcare providers may consider: Bacterial culture if infection is suspected Temporary discontinuation of semaglutide to assess symptom resolution Referral to allergy/immunology for suspected hypersensitivity reactions For type 2 diabetes patients only, alternative GLP-1 receptor agonist formulations (such as oral semaglutide/Rybelsus) if injection site reactions are recurrent and problematic Patients with confirmed hypersensitivity to semaglutide should not continue the medication

These medications mimic the effects of a hormone produced in the body that regulates blood sugar

We can't stress this enough: there is no universal 'Kaiser policy' on this

Reviewing the first round of Medicare price negotiations Back in August 2024, the White House announced lower prices for the first drugs chosen for Medicare price negotiations